Fascioliasis (Liver Fluke Disease) in Sheep and Goats

Fascioliasis is a parasitic disease of sheep and goats caused by the trematode liver flukes Fasciola hepatica (temperate regions) and Fasciola gigantica (tropical regions). The disease is characterized by acute, subacute, or chronic hepatitis and cholangitis, leading to progressive weight loss, anemia, hypoalbuminemia, submandibular edema (bottle jaw), and in acute cases, sudden death due to massive hepatic hemorrhage and necrosis. In sheep, acute fascioliasis is a major cause of mortality, particularly in late summer and autumn when metacercariae are ingested in large numbers. In goats, chronic fascioliasis is more common, resulting in reduced milk production, poor growth, and increased susceptibility to other diseases. The economic impact includes direct mortality, reduced weight gain, decreased wool and milk production, impaired reproductive performance, and increased culling rates. Fascioliasis is a production-limiting disease in grazing systems worldwide, with prevalence influenced by the presence of suitable intermediate snail hosts (Lymnaea spp.) and environmental conditions favoring cercarial shedding.

The primary causative agents are Fasciola hepatica and Fasciola gigantica, both trematodes belonging to the family Fasciolidae. Fasciola hepatica is the most common species in temperate climates, while Fasciola gigantica predominates in tropical and subtropical regions. The life cycle is indirect, requiring an intermediate host, typically freshwater snails of the genus Lymnaea (e.g., Lymnaea truncatula for F. hepatica, Lymnaea auricularia for F. gigantica). Adult flukes reside in the bile ducts of the definitive host (sheep, goats, cattle, and other ruminants). Eggs are passed in feces and hatch in water, releasing miracidia that penetrate the snail. Within the snail, they undergo asexual multiplication (sporocyst, rediae, cercariae). Cercariae are released from the snail and encyst on aquatic vegetation as metacercariae, which are the infective stage. Sheep and goats become infected by ingesting metacercariae-contaminated herbage. After ingestion, metacercariae excyst in the small intestine, penetrate the intestinal wall, and migrate through the peritoneal cavity to the liver. They then migrate through the liver parenchyma for 6-8 weeks, causing extensive tissue destruction and hemorrhage, before entering the bile ducts where they mature into adult flukes. The prepatent period is approximately 8-12 weeks. The severity of disease depends on the number of metacercariae ingested and the host's immune status. Acute fascioliasis occurs when large numbers of immature flukes migrate through the liver simultaneously, causing severe hepatic trauma and hemorrhage. Chronic fascioliasis results from the presence of adult flukes in the bile ducts, leading to chronic cholangitis, fibrosis, and biliary obstruction.

Fascioliasis affects both sheep and goats, but sheep are generally more susceptible to acute disease, while goats often develop chronic infections. The disease is more prevalent in temperate regions with high rainfall and in irrigated pastures where the snail intermediate host thrives. Outbreaks are common in late summer and autumn when metacercariae are abundant on pasture. The epidemiology is influenced by climatic factors, particularly temperature and moisture, which affect snail populations and cercarial shedding. In sheep, acute fascioliasis is seen in animals grazing contaminated pastures, especially in years with heavy rainfall. Chronic fascioliasis is more common in older animals and in goats, where the infection may persist for years. Morbidity can be high, with up to 100% of the flock exposed, and mortality in acute cases can reach 30-50% if untreated. Economic losses include death, weight loss, reduced wool and milk production, and increased susceptibility to other diseases. The disease is endemic in many parts of the world, including Europe, the Americas, Africa, and Asia. In the United States, fascioliasis is particularly problematic in the Gulf Coast states and the Pacific Northwest. The prevalence of Fasciola gigantica is higher in tropical regions of Africa and Asia, where it causes significant losses in small ruminant production.

The pathophysiology of fascioliasis is primarily due to the migratory activity of immature flukes through the liver parenchyma and the presence of adult flukes in the bile ducts. During the migratory phase, immature flukes cause mechanical destruction of hepatocytes and blood vessels, leading to hemorrhage, necrosis, and inflammation. This results in acute hepatitis, characterized by elevated liver enzymes (AST, GGT), hyperbilirubinemia, and anemia due to blood loss. The liver attempts to repair the damage by fibrosis, leading to the characteristic 'liver fluke tracks' seen on necropsy. In chronic fascioliasis, adult flukes in the bile ducts cause chronic cholangitis, bile duct hyperplasia, and periductal fibrosis. The flukes feed on blood and bile, leading to blood loss anemia and hypoalbuminemia. The chronic inflammation and fibrosis impair liver function, leading to reduced synthetic capacity (albumin, clotting factors) and impaired detoxification. The anemia is typically normocytic, normochromic, and regenerative, reflecting blood loss. Hypoalbuminemia contributes to submandibular edema (bottle jaw) and ascites. In goats, chronic fascioliasis may also lead to secondary copper deficiency due to impaired copper metabolism in the liver, resulting in poor growth and fleece quality. The immune response to Fasciola infection is complex, with a Th2-type response that is ineffective in clearing the infection, leading to chronicity. The parasite also secretes immunomodulatory molecules that suppress host immune responses, allowing survival and reproduction.

Several factors predispose sheep and goats to fascioliasis. The most important is grazing on pastures contaminated with metacercariae, particularly in wet, low-lying areas where snail habitats are present. High rainfall and moderate temperatures (15-25°C) favor snail reproduction and cercarial shedding, increasing pasture infectivity. Overcrowding and overgrazing increase the likelihood of ingesting metacercariae. Young animals are more susceptible to acute disease, while older animals may develop chronic infections. Animals with poor body condition or concurrent infections (e.g., parasitic gastroenteritis, clostridial diseases) are more severely affected. Management practices such as lack of pasture rotation, inadequate drainage, and failure to treat infected animals contribute to the persistence of the disease. Anthelmintic resistance in Fasciola populations, particularly to triclabendazole, is an emerging problem in some regions, making control more difficult. In goats, the disease may be exacerbated by copper deficiency, which impairs immune function and liver repair. Additionally, goats are more likely to browse, which may reduce exposure to metacercariae on pasture, but they can still become infected if they graze contaminated areas.

Clinical signs of fascioliasis vary depending on the stage and severity of infection. In acute fascioliasis, which occurs 2-6 weeks after ingestion of a large number of metacercariae, sheep may show sudden death without premonitory signs. Affected animals may exhibit depression, anorexia, abdominal pain, pale mucous membranes, and anemia. The liver is enlarged and painful on palpation. In subacute fascioliasis, signs include progressive weight loss, weakness, anemia, and submandibular edema (bottle jaw). In chronic fascioliasis, which is more common in goats and older sheep, signs include chronic weight loss, poor condition, reduced milk production, anemia, hypoalbuminemia, and bottle jaw. Diarrhea may be present in some cases. In goats, chronic fascioliasis may also cause reduced fertility and poor kid growth. The FAMACHA anemia score can be used to assess the degree of anemia, with scores of 3-5 indicating moderate to severe anemia. Submandibular edema is a classic sign of hypoalbuminemia and is often seen in chronic cases. In severe chronic cases, ascites and jaundice may be present. Neurological signs are rare but can occur if flukes migrate aberrantly to the brain or spinal cord. Flock-level signs include reduced weight gain, decreased wool and milk production, and increased mortality, particularly in acute outbreaks.

Differential diagnoses for fascioliasis include other causes of anemia, weight loss, and liver disease in sheep and goats. These include: 1) Haemonchosis (barber pole worm infection) - caused by Haemonchus contortus, a blood-sucking abomasal parasite. It causes acute anemia, bottle jaw, and sudden death, but is differentiated by the presence of high fecal egg counts (typically >5000 EPG) and the absence of liver lesions on necropsy. 2) Parasitic gastroenteritis (e.g., Teladorsagia, Trichostrongylus) - causes weight loss, diarrhea, and poor condition, but anemia is less prominent. Fecal egg counts and larval culture can differentiate. 3) Clostridial diseases (e.g., black disease, infectious necrotic hepatitis) - caused by Clostridium novyi type B, often associated with liver fluke migration. Black disease causes sudden death, and necropsy reveals necrotic liver lesions and the presence of clostridial organisms. 4) Johne's disease (paratuberculosis) - caused by Mycobacterium avium subsp. paratuberculosis, causes chronic weight loss and diarrhea, but anemia is not a feature. Diagnosis is by serology or PCR. 5) Copper deficiency - causes poor growth, anemia, and bone disorders, but liver enzymes are not elevated, and response to copper supplementation is seen. 6) Liver abscesses (e.g., Corynebacterium pseudotuberculosis) - cause weight loss and ill-thrift, but are less common and may be associated with caseous lymphadenitis. 7) Chronic fascioliasis must be differentiated from other causes of hypoalbuminemia, such as protein-losing enteropathy or nephropathy. 8) In goats, pregnancy toxemia may cause similar signs of depression and weight loss, but is differentiated by the presence of ketonemia and response to glucose therapy.

The diagnostic approach to fascioliasis involves a combination of history, clinical signs, laboratory tests, and necropsy findings. The algorithm is as follows: 1) Flock history: Consider the season, pasture management, and previous history of fascioliasis. 2) Clinical examination: Assess body condition, mucous membrane color (FAMACHA score), presence of submandibular edema, and signs of anemia. 3) Fecal examination: Collect fecal samples from affected animals and perform a sedimentation test to detect Fasciola eggs. Eggs are large (130-150 μm), operculated, and golden-brown. Fecal egg counts are not reliable in acute disease because eggs are not shed until 8-12 weeks post-infection. 4) Hematology and biochemistry: Measure packed cell volume (PCV), hemoglobin, total protein, albumin, and liver enzymes (AST, GGT). Anemia (PCV < 20%), hypoalbuminemia (< 2.5 g/dL), and elevated GGT (> 50 U/L) are suggestive of fascioliasis. 5) Serology: ELISA tests for Fasciola antibodies are available and can detect infection from 2-4 weeks post-infection. However, they do not distinguish between past and current infection. 6) Necropsy: If animals die, perform a thorough necropsy. In acute fascioliasis, the liver is enlarged, hemorrhagic, and shows characteristic migratory tracts. In chronic cases, the bile ducts are thickened, fibrotic, and contain adult flukes. 7) Liver biopsy: In live animals, a liver biopsy can be performed to detect flukes or eggs, but this is rarely done in practice. 8) Response to treatment: A positive response to a flukicide (e.g., triclabendazole) supports the diagnosis. 9) Differential diagnosis: Rule out other causes of anemia and weight loss, such as haemonchosis, using fecal egg counts and larval culture.

Laboratory findings in fascioliasis include: 1) Hematology: Normocytic, normochromic, regenerative anemia with decreased PCV (often < 20%), hemoglobin, and red blood cell count. Eosinophilia may be present during the migratory phase. 2) Serum biochemistry: Hypoalbuminemia (< 2.5 g/dL), elevated liver enzymes, particularly gamma-glutamyl transferase (GGT) and aspartate aminotransferase (AST). GGT is often elevated in chronic fascioliasis due to bile duct damage. Total bilirubin may be mildly elevated. 3) Fecal examination: Sedimentation test reveals Fasciola eggs in chronic infections. Eggs are large (130-150 μm), operculated, and golden-brown. Fecal egg counts are not quantitative but can be used to confirm infection. 4) Serology: ELISA for Fasciola antibodies is sensitive and specific, but cannot distinguish between past and current infection. 5) Liver biopsy: May show eggs or flukes, but is rarely performed. 6) Necropsy: In acute cases, the liver is enlarged, hemorrhagic, and shows migratory tracts. In chronic cases, the bile ducts are thickened, fibrotic, and contain adult flukes. 7) Other findings: Elevated globulins may be present due to chronic inflammation. In goats, copper levels may be low due to impaired liver metabolism.

Imaging modalities are not commonly used in the diagnosis of fascioliasis in sheep and goats, but ultrasonography can be helpful in some cases. Ultrasonography of the liver may reveal hepatomegaly, increased echogenicity, and dilated bile ducts in chronic cases. In acute fascioliasis, the liver may appear diffusely hyperechoic with areas of hemorrhage. Ultrasonography can also be used to assess the degree of ascites and submandibular edema. Radiography is not useful for liver fluke disease. Computed tomography (CT) is rarely used in small ruminant practice but could provide detailed images of liver pathology. However, these imaging modalities are not practical for routine diagnosis in the field. The diagnosis is primarily based on clinical signs, laboratory tests, and necropsy findings.

Histopathological findings in fascioliasis are characteristic. In acute fascioliasis, the liver shows extensive parenchymal necrosis, hemorrhage, and migratory tracts filled with eosinophilic debris and immature flukes. There is an intense inflammatory infiltrate consisting of eosinophils, macrophages, and lymphocytes. In chronic fascioliasis, the bile ducts are dilated, thickened, and fibrotic, with hyperplasia of the biliary epithelium. Adult flukes are present within the bile ducts, and there is periductal fibrosis and infiltration of mononuclear cells. The liver parenchyma may show fibrosis and nodular regeneration. In goats, chronic changes are similar but may be less severe. Cytological examination of liver aspirates or bile may reveal fluke eggs, but this is rarely performed. Histopathology is the gold standard for confirming the diagnosis and differentiating from other liver diseases.

Treatment of fascioliasis involves the use of flukicidal drugs. The drug of choice for acute fascioliasis is triclabendazole, which is effective against both immature and adult flukes. The recommended dose is 10 mg/kg orally, and it is the only drug effective against early immature stages (2-4 weeks). For chronic fascioliasis, other flukicides such as albendazole (15 mg/kg orally), clorsulon (7 mg/kg orally or SC), or nitroxynil (10 mg/kg SC) can be used. However, these drugs are less effective against immature flukes. In acute outbreaks, treatment should be initiated immediately to reduce mortality. Supportive therapy may include fluid therapy, iron supplementation, and nutritional support. In severe anemia, blood transfusions may be necessary, but this is rarely practical in flock situations. In addition to treatment, control measures should be implemented, including pasture management, snail control, and strategic deworming. Anthelmintic resistance to triclabendazole has been reported in some regions, so it is important to monitor efficacy. In goats, doses may need to be adjusted due to differences in metabolism; for example, albendazole is often used at a higher dose (20 mg/kg) in goats. Withdrawal times for meat and milk must be observed according to label instructions.

The prognosis for fascioliasis depends on the stage and severity of infection. In acute fascioliasis, the prognosis is poor, with high mortality if treatment is delayed. Early treatment with triclabendazole can reduce mortality, but animals that survive may have permanent liver damage. In subacute and chronic cases, the prognosis is guarded to good with appropriate treatment and management. Animals with chronic fascioliasis may recover slowly, and weight gain and production may not return to normal for several months. In goats, chronic fascioliasis can be managed, but the disease may cause long-term production losses. The prognosis is worse in animals with concurrent diseases, poor body condition, or severe anemia. Flock-level prognosis depends on the effectiveness of control measures and the prevalence of the disease in the environment.

Follow-up care for fascioliasis includes: 1) Monitor treated animals for clinical improvement, including weight gain, resolution of anemia, and reduction in submandibular edema. 2) Repeat fecal examinations 4-6 weeks after treatment to assess efficacy. If eggs are still present, consider anthelmintic resistance and switch to a different drug class. 3) Implement a strategic deworming program based on the epidemiology of the disease in the region. This may include treating animals in late autumn and early spring to reduce pasture contamination. 4) Improve pasture management by draining wet areas, rotating pastures, and avoiding grazing on contaminated pastures during high-risk periods. 5) Control snail populations by using molluscicides or biological control methods, although these are often impractical. 6) Provide adequate nutrition, especially protein and minerals, to support liver regeneration and immune function. 7) Monitor liver enzyme levels (GGT, AST) to assess recovery. 8) In goats, monitor copper status and supplement if necessary. 9) Educate producers about the importance of biosecurity and quarantine of new animals to prevent introduction of the disease.

Clinical pearls: 1) Acute fascioliasis should be suspected in sheep that die suddenly in late summer/autumn on wet pastures. 2) Triclabendazole is the only drug effective against early immature flukes; use it for acute outbreaks. 3) Fecal sedimentation is more sensitive than flotation for detecting Fasciola eggs. 4) Elevated GGT is a sensitive indicator of chronic fascioliasis. 5) In goats, use higher doses of albendazole (20 mg/kg) due to faster metabolism. 6) Submandibular edema (bottle jaw) is a classic sign of hypoalbuminemia in chronic fascioliasis. 7) Always consider fascioliasis in the differential diagnosis of anemia and weight loss in grazing sheep and goats. Pitfalls: 1) Do not rely on fecal egg counts in acute disease; eggs are not shed until 8-12 weeks post-infection. 2) Do not use drugs that are ineffective against immature flukes (e.g., clorsulon) in acute outbreaks. 3) Avoid underdosing flukicides; calculate doses accurately based on body weight. 4) Do not ignore anthelmintic resistance; monitor efficacy with fecal egg count reduction tests. 5) Do not forget to treat all animals in the flock, not just clinically affected ones. 6) Do not overlook the role of snail control and pasture management in preventing reinfection. 7) Be cautious with copper supplementation in sheep, as they are more susceptible to copper toxicity than goats.

Current drug protocols for fascioliasis in sheep and goats are based on Plumb's Veterinary Drug Handbook and AASRP guidelines. The following are recommended protocols: 1) Triclabendazole: 10 mg/kg orally as a single dose. Effective against immature and adult flukes. Withdrawal times: meat 28 days, milk 7 days (check label). 2) Albendazole: 15 mg/kg orally for sheep, 20 mg/kg for goats. Effective against adult flukes and some immature stages. Withdrawal times: meat 7 days (sheep), 14 days (goats); milk 3 days (sheep), 7 days (goats). 3) Clorsulon: 7 mg/kg orally or SC. Effective against adult flukes. Withdrawal times: meat 14 days, milk 7 days. 4) Nitroxynil: 10 mg/kg SC. Effective against adult flukes. Withdrawal times: meat 30 days, milk 5 days. 5) Ivermectin: Not effective against flukes, but may be used for concurrent nematode infections. 6) Supportive therapy: For anemic animals, provide iron dextran (50 mg/kg IM) and vitamin B12. In severe cases, blood transfusion may be considered. 7) In acute outbreaks, treat all animals in the flock with triclabendazole, and repeat in 4-6 weeks if necessary. 8) For chronic cases, treat with a flukicide effective against adult flukes, such as albendazole or clorsulon. 9) Always observe withdrawal times for meat and milk to ensure food safety.

Evidence-based literature on fascioliasis in small ruminants includes numerous studies on the epidemiology, diagnosis, treatment, and control of the disease. Key findings include: 1) Triclabendazole is the most effective drug for acute fascioliasis, with efficacy against early immature stages (Boray et al., 1983). 2) The prevalence of fascioliasis is influenced by climatic factors, particularly rainfall and temperature, which affect snail populations (Ollerenshaw, 1971). 3) Fasciola hepatica infection causes significant economic losses in sheep production, including reduced weight gain and wool production (Spithill et al., 1999). 4) Anthelmintic resistance to triclabendazole has been reported in several countries, highlighting the need for integrated control strategies (Fairweather, 2011). 5) Serological tests, such as ELISA, are useful for early diagnosis and flock screening (Sánchez-Andrade et al., 2002). 6) Control measures, including pasture management and strategic deworming, are effective in reducing the incidence of fascioliasis (Taylor et al., 2015). 7) In goats, fascioliasis is often chronic and may be associated with copper deficiency, which can be managed with copper supplementation (Smith & Sherman, 2009). 8) The use of FAMACHA scoring is not directly applicable to fascioliasis, but it can be used to monitor anemia in flocks. 9) Recent research has focused on the development of vaccines against Fasciola, but no commercial vaccine is currently available (Dalton et al., 2013). 10) Integrated parasite management, including the use of targeted selective treatments, is recommended to reduce the development of anthelmintic resistance (Charlier et al., 2014).